Thus, while the involvement of DCTN1 mutations in ALS/FTD pathogenesis is clear, the question whether these mutations cause disease through gain -or loss-of-function remains a source of debate and requires further investigation. The gene discussed is DCTN1; the disease is amyotrophic lateral sclerosis.